Cargando…
Innovation in clinical trial methodologies : lessons learned during the Corona pandemic /
"Innovation in Clinical Trial Methodologies: Lessons Learned during the Corona Pandemic presents a selection of updated chapters from Re-Engineering Clinical Trials that feature innovative options and methods in clinical trials. The Coronavirus pandemic is an accelerator for digitalization in m...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Amsterdam :
Elsevier/Academic Press,
[2021]
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_on1203119792 | ||
| 003 | OCoLC | ||
| 005 | 20231120010517.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 201104t20212021enka ob 001 0 eng d | ||
| 040 | |a YDX |b eng |e rda |e pn |c YDX |d MMU |d OCLCO |d OPELS |d OCLCA |d N$T |d OCLCA |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO |d K6U |d OCL |d OCLCQ |d OCLCO | ||
| 020 | |a 0323860060 |q (electronic book) | ||
| 020 | |a 9780128244906 |q (electronic bk.) | ||
| 020 | |a 0128244909 |q (electronic bk.) | ||
| 020 | |a 9780323860062 |q (electronic bk.) | ||
| 035 | |a (OCoLC)1203119792 | ||
| 050 | 4 | |a RM301.27 | |
| 060 | 4 | |a QV 771.4 | |
| 082 | 0 | 4 | |a 615.19 |2 23 |
| 245 | 0 | 0 | |a Innovation in clinical trial methodologies : |b lessons learned during the Corona pandemic / |c edited by Peter Schueler. |
| 264 | 1 | |a Amsterdam : |b Elsevier/Academic Press, |c [2021] | |
| 264 | 4 | |c �2021 | |
| 300 | |a 1 online resource (xvi, 185 pages) : |b illustrations (chiefly color) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 500 | |a Preceded by: Re-engineering clinical trials : best practices for streamlining the development process / edited by Peter Sch�uler, Brendan Buckley. [2015]. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a Introduction -- -- Alternative study concepts requiring less patients -- -- Studies with less patient interaction -- -- Digitalized planning: digitalized studies -- -- From data to decisions -- -- Conclusions. | |
| 520 | |a "Innovation in Clinical Trial Methodologies: Lessons Learned during the Corona Pandemic presents a selection of updated chapters from Re-Engineering Clinical Trials that feature innovative options and methods in clinical trials. The Coronavirus pandemic is an accelerator for digitalization in many industries, including clinical trials. This book considers best practices, alternative study concepts requiring fewer patients, studies with less patient interaction, the design of "virtualized" protocols, and moving from data to decisions. This book will be helpful to pharmacologists, physicians and clinical researchers involved in the process of clinical development and clinical trial design. Considers multiple digital and virtual strategies Explores best practices, including the use of reduced patient involvement Brings together expert, trusted information to increase the efficiency and effectiveness of clinical trials"--Publisher's description | ||
| 588 | 0 | |a Online resource; title from electronic title page (ProQuest Ebook Central, viewed on January 19, 2021). | |
| 650 | 0 | |a Drugs |x Testing. | |
| 650 | 0 | |a Drug development |x Safety measures. | |
| 650 | 0 | |a Clinical trials. | |
| 650 | 0 | |a Drug development |x Economic aspects. | |
| 650 | 0 | |a Drugs |x Design. | |
| 650 | 1 | 2 | |a Clinical Trials as Topic |0 (DNLM)D002986 |
| 650 | 1 | 2 | |a Drug Design |0 (DNLM)D015195 |
| 650 | 2 | 2 | |a Drug Approval |0 (DNLM)D017277 |
| 650 | 2 | 2 | |a SARS-CoV-2 |0 (DNLM)D000086402 |
| 650 | 6 | |a M�edicaments |x Essais cliniques. |0 (CaQQLa)201-0102966 | |
| 650 | 6 | |a M�edicaments |0 (CaQQLa)201-0306620 |x D�eveloppement |0 (CaQQLa)201-0306620 |x S�ecurit�e |0 (CaQQLa)201-0373949 |x Mesures. |0 (CaQQLa)201-0373949 | |
| 650 | 6 | |a �Etudes cliniques. |0 (CaQQLa)201-0070699 | |
| 650 | 6 | |a M�edicaments |0 (CaQQLa)201-0306620 |x D�eveloppement |0 (CaQQLa)201-0306620 |x Aspect �economique. |0 (CaQQLa)201-0374333 | |
| 650 | 6 | |a M�edicaments |x Conception. |0 (CaQQLa)201-0203461 | |
| 650 | 7 | |a Drugs |x Design |2 fast |0 (OCoLC)fst00898790 | |
| 650 | 7 | |a Clinical trials |2 fast |0 (OCoLC)fst00864429 | |
| 650 | 7 | |a Drugs |x Testing |2 fast |0 (OCoLC)fst00898940 | |
| 700 | 1 | |a Sch�uler, Peter |c M.D., |e editor. | |
| 730 | 0 | |i Preceded by: |a Re-engineering clinical trials. | |
| 776 | 0 | 8 | |i Print version: |t Innovation in clinical trial methodologies. |d London : Academic Press, [2021] |z 9780128244906 |w (OCoLC)1197745126 |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780128244906 |z Texto completo |